Skip to main content
SpringerLink
Log in

N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

N-Acetyltransferase 2 (NAT2) is a polymorphic gene encoding the enzyme that metabolizes arylamine and hydrazine moieties. The NAT2 rs1799930 (G590A) may change drug-induced toxicity and affect cancer susceptibility. To investigate the association between NAT2 rs1799930 polymorphism and susceptibility to lung cancer, we performed a hospital-based case–control study, including 259 lung squamous carcinoma patients and 375 cancer-free hospital controls who were matched by age. A total of 10 ml of venous blood from each patient was collected for the genotype testing. NAT2 rs1799930 polymorphism was analyzed by TaqMan allelic discrimination. Our results showed the evidence by the stratified analysis that smokers with dominant genetic model and A allele in NAT2 rs1799930 decreased risk of lung squamous carcinoma with adjusted OR of 0.64 (95 % CI 0.42–0.96, P = 0.032) and 0.74 (95 % CI 0.54–1.00, P = 0.049), respectively. The significantly increased risk of lung squamous carcinoma was observed in those whose pack-years ≥30 or smoking-index ≥400 with adjusted OR of 3.62 (95 % CI 2.49–5.26, P < 0.001) and 4.29 (95 % CI 2.90–6.36, P < 0.001), respectively. In conclusion, NAT2 rs1799930 polymorphism is an important factor of lung squamous carcinoma resistance in Chinese smoking males. People who smoked heavily had a significantly increased risk of lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blot WJ, Li JY, Taylor PR, Li B. Lung cancer and vitamin supplementation. N Engl J Med. 1994;331:614.

    Article  CAS  PubMed  Google Scholar 

  2. Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis. 2007;28:1287–93.

    Article  CAS  PubMed  Google Scholar 

  3. Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology. 2003;8:17–21.

    Article  PubMed  Google Scholar 

  4. Chen WQ. Estimation of cancer incidence and mortality in China in 2004–2005. Zhonghua Zhong Liu Za Zhi. 2009;31:664–8.

    PubMed  Google Scholar 

  5. Nishikawa A, Mori Y, Lee IS, Tanaka T, Hirose M. Cigarette smoking, metabolic activation and carcinogenesis. Curr Drug Metab. 2004;5:363–73.

    Article  CAS  PubMed  Google Scholar 

  6. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85.

    Article  CAS  PubMed  Google Scholar 

  7. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 1990;9:193–203.

    Article  CAS  PubMed  Google Scholar 

  8. Hickman D, Pope J, Patil SD, Fakis G, Smelt V, et al. Expression of arylamine N-acetyltransferase in human intestine. Gut. 1998;42:402–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res. 1993;53:509–14.

    CAS  PubMed  Google Scholar 

  10. De Stefani E, Boffetta P, Mendilaharsu M, Carzoglio J, Deneo-Pellegrini H. Dietary nitrosamines, heterocyclic amines, and risk of gastric cancer: a case–control study in Uruguay. Nutr Cancer. 1998;30:158–62.

    Article  PubMed  Google Scholar 

  11. Hickman D, Risch A, Camilleri JP, Sim E. Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics. 1992;2:217–26.

    Article  CAS  PubMed  Google Scholar 

  12. Nikishina MV, Vavilin VA, Makarova SI, Lyakhovich VV. Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer. Bull Exp Biol Med. 2007;143:83–6.

    Article  CAS  PubMed  Google Scholar 

  13. Zheng D (2010) Case control study of the association between CYP1A1 NAT2 GSTM1 genetic polymorphism and lung cancer risk. Tian Jin Medical University Master’s Dissertation.

  14. Windmill KF, Gaedigk A, Hall PM, Samaratunga H, Grant DM, et al. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci. 2000;54:19–29.

    Article  CAS  PubMed  Google Scholar 

  15. Yamada S, Tang M, Richardson K, Halaschek-Wiener J, Chan M, et al. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population. Pharmacogenomics. 2009;10:1433–45.

    Article  CAS  PubMed  Google Scholar 

  16. Pande JN, Pande A, Singh SP. Acetylator status, drug metabolism and disease. Natl Med J India. 2003;16:24–6.

    CAS  PubMed  Google Scholar 

  17. Zabost A, Roszkowska-Sliz B, Wiatr E, Radzikowska E, Rogala E, et al. Polymorphism in the N-acetyltransferase 2 gene in patients with lung cancer. Short communication. Pneumonol Alergol Pol. 2012;80:323–8.

    CAS  PubMed  Google Scholar 

  18. Osawa Y, Osawa KK, Miyaishi A, Higuchi M, Tsutou A, et al. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pac J Cancer Prev. 2007;8:103–8.

    PubMed  Google Scholar 

  19. Cui D, Wang Z, Zhao E, Ma J, Lu W. NAT2 polymorphism and lung cancer risk: a meta-analysis. Lung Cancer. 2011;73:153–7.

    Article  PubMed  Google Scholar 

  20. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, et al. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13:2241–7.

    Article  CAS  PubMed  Google Scholar 

  21. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 1994;54:5801–3.

    CAS  PubMed  Google Scholar 

  22. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–71.

    Article  CAS  PubMed  Google Scholar 

  23. Liu X, Lin XJ, Wang CP, Yan KK, Zhao LY, et al. Association between smoking and p53 mutation in lung cancer: a meta-analysis. Clin Oncol (R Coll Radiol). 2014;26:18–24.

    Article  CAS  Google Scholar 

  24. Shaykhiev R, Sackrowitz R, Fukui T, Zuo WL, Chao IW, et al. Smoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancer. Am J Respir Cell Mol Biol. 2013;49:418–25.

    Article  CAS  PubMed  Google Scholar 

  25. He F, Chang SC, Wallar GM, Zhang ZF, Cai L. Association of XRCC3 and XRCC4 gene polymorphisms, family history of cancer and tobacco smoking with non-small-cell lung cancer in a Chinese population: a case–control study. J Hum Genet. 2013;58:679–85.

    Article  CAS  PubMed  Google Scholar 

  26. Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, et al. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomark Prev. 2002;11:15–21.

    CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that there is no conflict of interest in this study.

Author information

Authors and Affiliations

  1. Department of Epidemiology, School of Public Health, China Medical University, Shenyang, 110001, China

    Fangshuo Tian, Yue Zhang, Yangwu Ren, Li Shen, Wei Wu & Baosen Zhou

  2. Key Laboratory of Cancer Etiology and Intervention, University of Liaoning Province, Shenyang, 110001, China

    Fangshuo Tian, Yue Zhang, Yangwu Ren, Li Shen, Wei Wu & Baosen Zhou

Authors
  1. Fangshuo Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yue Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yangwu Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Baosen Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baosen Zhou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, F., Zhang, Y., Ren, Y. et al. N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males. Med Oncol 31, 90 (2014). https://doi.org/10.1007/s12032-014-0090-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0090-9

Keywords

Search

Navigation